Sweeteners · Metabolic & Cardiometabolic
added sugar intake above roughly 100-150 kcal per day increases cardiometabolic risk
In plain terms: Does eating a lot of added sugar raise heart-and-metabolic disease risk?
Part of: • Added sugar
The strongest, best-established piece is sugary drinks: sugar-sweetened-beverage intake reliably raises diabetes and cardiometabolic risk (underpinning the AHA limits Lustig co-authored). For TOTAL added sugar the signal is weaker and more mixed — recent dose-response meta-analyses pin much of the harm on beverages rather than sugar per se — so the broad 'limit all added sugar' framing lands at modest support.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
The evidence (14)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Johnson 2013 · Diabetes | mechanism | supports | low | Provides fructose/uric-acid mechanistic basis linking added-sugar excess to metabolic syndrome and diabetes. |
| Te Morenga 2012 · BMJ | meta-analysis | supports | high | Higher free-sugar (especially beverage) intake increased body weight in ad libitum diets and cohorts — a core cardiometabolic risk driver. |
| Sun 2023 · Adv Nutr | meta-analysis | supports | moderate | Dose-response meta-analysis of 64 cohorts found only SSBs (not fruit, cereal or other fructose sources) were positively associated with CVD morbidity/mortality. |
| Aswathiah S et al 2022 · study_type: RCT | RCT | supports | low | In a 90-day open-label RCT of 60 healthy Indian adults, substituting a lower-calorie sugar/stevia blend for regular sugar produced significantly greater reductions in weight, waist circumference, total cholesterol, triglycerides, LDL, and V |
| Basu 2013 · PLoS One | observational | supports | low | Population-level sugar availability tracks diabetes prevalence, consistent with (but not proof of) added-sugar thresholds mattering. |
| Te Morenga 2014 · Am J Clin Nutr | meta-analysis | supports | high | RCT meta-analysis: higher sugar intake raised triglycerides, total/LDL cholesterol and blood pressure independent of weight change. |
| Rodríguez LA et al 2026 · study_type: observational | observational | mixed | moderate | [directional null: no dose-response = disconfirming] In 12,484 US Hispanic/Latino adults (5,576 at 6.2-yr follow-up), added sugars quintile showed no cross-sectional (OR=1.01 top vs bottom quintile) or longitudinal association with metaboli |
| Huang 2023 · BMJ | meta-analysis | supports | moderate | Umbrella review of 73 meta-analyses found high dietary sugar (esp. SSBs) associated with adverse cardiometabolic outcomes, though evidence quality varied by outcome. |
| Della Corte 2025 · Adv Nutr | meta-analysis | mixed | high | Dose-response meta-analysis of 29 cohorts found SSBs and fruit juice raised T2D risk, but total sugar/sucrose did not, challenging blanket 'all added sugar' claims. |
| Yang 2022 · Nutrients | meta-analysis | mixed | low | Women's Health Initiative cohort plus network meta-analysis found added sugar >=15% energy and >=1 SSB/day raised CVD risk, though pooled cohort patterns were heterogeneous. |
| Khan 2019 · Mayo Clin Proc | meta-analysis | mixed | moderate | Meta-analysis found added/total fructose-containing sugars showed inconsistent CVD associations, with harm concentrated in sugar-sweetened beverages rather than sugar per se. |
| Huang 2023 · Nutrition | meta-analysis | supports | moderate | Dose-response meta-analysis of prospective cohorts linked higher added sugar, fructose and sucrose to increased cardiovascular and all-cause mortality. |
| Malik 2010 · Diabetes Care | meta-analysis | supports | moderate | Meta-analysis linked higher SSB consumption to increased incidence of metabolic syndrome and type 2 diabetes. |
| Meng 2021 · Nutrients | observational | supports | moderate | Dose-response meta-analysis of 34 cohorts found each extra daily SSB serving raised T2D/CVD/mortality risk by ~27%. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.